These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1471536)

  • 1. Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice.
    Ohrberg S; Christiansen PE; Severin B; Calberg H; Nilakantan B; Borup A; Søgaard J; Larsen SB; Loldrup D; Bahr B
    Acta Psychiatr Scand; 1992 Dec; 86(6):437-44. PubMed ID: 1471536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression.
    Claghorn JL; Feighner JP
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):23S-27S. PubMed ID: 8106652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study comparing paroxetine placebo and imipramine in depressed patients.
    Feighner JP; Cohn JB; Fabre LF; Fieve RR; Mendels J; Shrivastava RK; Dunbar GC
    J Affect Disord; 1993 Jun; 28(2):71-9. PubMed ID: 8354771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients.
    Arminen SL; Ikonen U; Pulkkinen P; Leinonen E; Mahlanen A; Koponen H; Kourula K; Ryyppö J; Korpela V; Lehtonen ML
    Acta Psychiatr Scand; 1994 Jun; 89(6):382-9. PubMed ID: 8085467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients.
    Feighner JP
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():31-5. PubMed ID: 1431008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct cost of depression: analysis of treatment costs of paroxetine versus Imipramine in Canada.
    Lapierre Y; Bentkover J; Schainbaum S; Manners S
    Can J Psychiatry; 1995 Sep; 40(7):370-7. PubMed ID: 8548716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxetine and amitriptyline in the treatment of depression in general practice.
    Christiansen PE; Behnke K; Black CH; Ohrström JK; Bork-Rasmussen H; Nilsson J
    Acta Psychiatr Scand; 1996 Mar; 93(3):158-63. PubMed ID: 8739658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements.
    Nielsen OA; Morsing I; Petersen JS; Larsen T; Møller SE; Manniche PM; Skausig OB
    Acta Psychiatr Scand; 1991 Sep; 84(3):233-41. PubMed ID: 1835251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.
    Nielsen BM; Behnke K; Arup P; Christiansen PE; Geisler A; Ipsen E; Maach-Møller B; Ohrberg SC
    Acta Psychiatr Scand; 1993 Apr; 87(4):269-72. PubMed ID: 8488748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of major depressive disorder with paroxetine.
    Duboff EA
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):28S-33S. PubMed ID: 8106653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.
    Elliott AJ; Uldall KK; Bergam K; Russo J; Claypoole K; Roy-Byrne PP
    Am J Psychiatry; 1998 Mar; 155(3):367-72. PubMed ID: 9501747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia.
    Katona CL; Hunter BN; Bray J
    Int J Geriatr Psychiatry; 1998 Feb; 13(2):100-8. PubMed ID: 9526179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy.
    Lauritzen L; Odgaard K; Clemmesen L; Lunde M; Ohrström J; Black C; Bech P
    Acta Psychiatr Scand; 1996 Oct; 94(4):241-51. PubMed ID: 8911559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.